As of Thursday, January 29, Nautilus Biotechnology, Inc.’s NAUT share price has dipped by 5.58%, which has investors questioning if this is right time to buy.
Gregory Garrabrants and Derrick Walsh will provide prepared remarks on the financial and operational results for the quarter ended December 31, 2025, then open up the call for Q&A. Before I begin, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results